Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Adolor Corporation GlaxoSmithKline |
---|---|
Information provided by: | Adolor Corporation |
ClinicalTrials.gov Identifier: | NCT00241722 |
Adults who are taking opioid therapy for persistent non-cancer pain and have resulting opioid-induced bowel dysfunction (OBD) will be randomized (1:1) to alvimopan or placebo. The primary objective of this phase 3 long-term safety study is to compare alvimopan with placebo for safety and tolerability in the treatment of OBD.
The primary safety endpoint is based on the frequency of reported adverse events. Subjects will be required to attend 8 clinic visits over approximately 1 year.
Condition | Intervention | Phase |
---|---|---|
Bowel Dysfunction Constipation |
Drug: alvimopan |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Parallel Assignment, Safety/Efficacy Study |
Official Title: | A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain |
Estimated Enrollment: | 750 |
Study Start Date: | August 2005 |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion criteria:
Exclusion criteria:
Study Director: | GSK Clinical Trials, MD | GlaxoSmithKline |
Responsible Party: | GSK ( Study Director ) |
Study ID Numbers: | SB-767905/014 |
Study First Received: | October 17, 2005 |
Last Updated: | March 6, 2009 |
ClinicalTrials.gov Identifier: | NCT00241722 History of Changes |
Health Authority: | United States: Food and Drug Administration |
bowel dysfunction constipation gastrointestinal opioids |
pain non-cancer pain opioid-induced |
Signs and Symptoms Signs and Symptoms, Digestive Constipation Central Nervous System Depressants |
Pain Peripheral Nervous System Agents Analgesics Analgesics, Opioid |
Signs and Symptoms Signs and Symptoms, Digestive Sensory System Agents Therapeutic Uses Physiological Effects of Drugs Constipation |
Central Nervous System Depressants Peripheral Nervous System Agents Analgesics Central Nervous System Agents Pharmacologic Actions Analgesics, Opioid |